Home Stock

Stock Research: Zydus

Independent stock analysis through peer comparison: Get the 360° View as an objective basis for stock decision-making and explore the detailed ranks.

Zydus

NSI:ZYDUSLIFE INE010B01027
19
  • Value
    45
  • Growth
    46
  • Safety
    Safety
    23
  • Combined
    21
  • Sentiment
    36
  • 360° View
    360° View
    19
Unlock
What factors are driving this 360° View?
Subscribe to View
Company Description

Zydus Lifesciences Limited is an India-based global life sciences company focused on discovering, developing, manufacturing, and marketing healthcare therapies. Its main businesses include integrated pharmaceutical operations, active pharmaceutical ingredients (API), human formulations, animal health and veterinary products, and health and wellness products, with products like Lipaglyn and Ujvira. The company has a global presence, marketing products in the United States, India, Europe, and emerging markets. In the last fiscal year, the company had a market cap of $11341 million, profits of $1978 million, and revenue of $2720 million.

more

ANALYSIS: With an Obermatt 360° View of 19 (better than 19% compared with alternatives), overall professional sentiment and financial characteristics for the stock Zydus are critical, mostly below average. The 360° View is based on consolidating four consolidated indicators, with all four indicators below average for Zydus. The consolidated Value Rank has a low rank of 45 which means that the share price of Zydus is on the higher side compared with typical size in indicators such as revenues, profits, and invested capital. This means the stock price is higher than for 55% of alternative stocks in the same industry. The consolidated Growth Rank also has a low rank of 46, which means that the company exhibits below-average growth momentum when looking at financial metrics such as revenue, profit, and invested capital growth as well as stock returns. This means that growth is lower than for 46% of competitors in the same industry. The consolidated Safety Rank has a riskier rank of 23, which means that the company has a riskier financing structure than 77% comparable companies when looking at the amount of its debt, its refinancing requirements, and its ability to service debt. Finally, the consolidated Sentiment Rank has a low rank of 36, which means that professional investors are more pessimistic about the stock than for 64% of alternative investment opportunities. ...read more

more
Strongest Rank 360° View
Weakest Rank Profit Growth
Country India
Industry Pharmaceuticals
Size X-Large
Website zyduslife.com
Index
Zydus stock price by TradingView. Not sourced by Obermatt.
Similar Add to Watchlist Similar See Similar Stocks
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 30-Jul-2026.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Value
Identifies how good a value the stock is.
Good Value Expensive
Combined
Consolidated view across Value, Growth, and Safety.
Good Tread Carefully
Growth
Shows a company's growth potential.
High Growth Tough Times
Sentiment
Shows what the market thinks of a stock.
Positive Sentiment Skepticism
Safety
Safety
Assesses how financially secure a company is.
Well-Financed High Leverage
360° View
360° View
Holistic stock analysis: all key non-/financial metrics
Good Watch Out

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
45 67 67 75
Growth
46 41 35 19
Safety
Safety
23 79 49 47
Sentiment
36 83 88 26
360° View
360° View
19 93 82 35
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Analyst Opinions
28 23 38 13
Opinions Change
67 81 48 49
Pro Holdings
n/a 85 99 94
Market Pulse
55 92 79 15
Sentiment
36 83 88 26
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
45 67 67 75
Growth
46 41 35 19
Safety Safety
23 79 49 47
Combined
21 87 55 39
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Price vs. Sales (P/S)
38 50 61 70
Price vs. Earnings (P/E)
41 73 68 74
Price vs. Book (P/B)
37 58 69 69
Dividend Yield
51 44 45 52
Value
45 67 67 75
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Revenue Growth
52 18 20 22
Profit Growth
79 67 67 39
Capital Growth
19 31 12 66
Stock Returns
57 57 89 23
Growth
46 41 35 19
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Leverage
23 74 62 42
Refinancing
46 44 52 62
Liquidity
52 80 48 39
Safety Safety
23 79 49 47

Similar Stocks

Discover high‑ranked alternatives to Zydus and broaden your portfolio horizons.

Tech Mahindra

NSI:TECHM
Country: India
Industry: IT Consulting & oth. Services
Size: X-Large
Full Stock Analysis

Gujarat Gas

NSI:GUJGASLTD
Country: India
Industry: Gas Utilities
Size: Large
Full Stock Analysis

AIA Engineering

NSI:AIAENG
Country: India
Industry: Industrial Machinery
Size: Medium
Full Stock Analysis

Aurobindo Pharma

NSI:AUROPHARMA
Country: India
Industry: Pharmaceuticals
Size: X-Large
Full Stock Analysis

Frequently Asked
Questions

This is a highly risky stock investment proposition as all consolidated ranks are below-average. There are no compelling arguments to support this stock based on current information. It is not recommended for any investor profile. However, performance does change, so it could we worth keepin on a watchlist.

Obermatt provides unbiased stock analysis as a completely independent third party. We have no conflicts of interest with individual stock titles. Our data-driven analysis is based on algorithms honed over twelve years, giving you analysis that is free from personal bias and conflicts of interest.

The 360° View Rank indicates a company's overall performance across all major financial and non-financial metrics tracked by Obermatt. A 360° View Rank of 75 means the company is more well-rounded than 75% of similar companies. A high score indicates that the company is strong across the board; it is attractively priced, growing sustainably, financially stable, and well-regarded by the market. Learn more.

Become an Obermatt subscriber and see all of the similar stocks here.

OTHER FEATURES

Use the Platform to its Fullest

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.

What Our Customers Say

See how Obermatt improved their investing:

Review us See More Google Reviews